Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis (Q73081846)
Jump to navigation
Jump to search
scientific article published on 01 February 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis |
scientific article published on 01 February 1997 |
Statements
Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product P16INK4A in ovarian cancer is associated with progression and unfavourable prognosis (English)
Y Dong
M D Walsh
M A McGuckin
B G Gabrielli
M C Cummings
R G Wright
T Hurst
1 February 1997